Autopsy report · NCT02197286

Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia

“Personnel changes at study site.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

NYU Langone Health

Sponsor type

University, hospital or other

Conditions

Schizophrenia; Schizoaffective Disorder

Interventions

Cholecalciferol; Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation
  “Change in study personnel.” (84% match in meaning)
• Improving Functional Ability in Chronic TBI With Intensive Rehabilitation Robotic Gait Training
  “Changes in personnel at Institution.” (79% match in meaning)
• Cerebral NIRS Monitoring During Anesthesia in Neonates and Infants
  “Study investigators changed institution” (71% match in meaning)
• The Effect of Ketamine in the Prevention of Hypoventilation in Patients Undergoing Deep Sedation Using Propofol and Fentanyl
  “Change in personnel” (69% match in meaning)
• A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
  “Study design was changed” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.